Tubular Markers in Response to Saxagliptin Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
the study aims to investigate whether treatment with saxagliptin would induce beneficial changes in renal NGAL and L-FABP biomarkers and if they would be used as a tool to identify patients\' categories with a particular renal response to DPP-4inhibition. Secondly, to find an association between NGAL and L-FABP, and the relevant renal parameters for both baseline values and rate of changes across defined time points.
Epistemonikos ID: 8f8cfea19c6b88e57cbfe32dc3b7e1952008fc7d
First added on: May 07, 2024